Clinical Study
Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer
Table 4
Correlations between tumour-infiltrating lymphocytes (TILs) and specific T cell subsets and grade of pathological response to NAC(1) (Spearman’s correlation coefficient (rho)) in women with LLABCs(2).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NAC: neoadjuvant chemotherapy; (2)LLABCs: large and locally advanced breast cancers; (3)pathological responses were graded from grades 1 to 5 (grade 1 (no loss of tumour cells), grade 2 (<30% loss of invasive disease), grade 3 (30–90% loss of invasive disease), grade 4 (>90% loss of invasive disease), and grade 5 (complete pathological response, no residual invasive disease)); statistically significant. |